Osteosarcoma is considered to be a highly malignant tumor affecting primarily long bones. It metastasizes widely, primarily to the lungs, resulting in poor survival rates of between 19 and 30%. Standard treatment consists of surgical removal of the affected site, with neoadjuvant and adjuvant chemotherapy commonly used, with the usual side effects and complications. There is a need for new treatments in this area, and silver nanoparticles (AgNPs) are one potential avenue for exploration. AgNPs have been found to possess antitumor and cytotoxic activity in vitro, by demonstrating decreased viability of cancer cells through cell cycle arrest and subsequent apoptosis. Integral to these pathways is tumor protein p53, a tumor suppressor which plays a critical role in maintaining genome stability by regulating cell division, after DNA damage. The purpose of this study was to determine if p53 mediates any difference in the response of the osteosarcoma cells in vitro when different sizes and concentrations of AgNPs are administered. Two cell lines were studied: p53‐expressing HOS cells and p53‐deficient Saos‐2 cells. The results of this study suggest that the presence of protein p53 significantly affects the efficacy of AgNPs on osteosarcoma cells.

During cancer initiation, normal cells acquire mutations disrupting standard cellular processes, activating oncogenes and inactivating tumor suppressor genes, acquiring the well-described hallmarks of cancer on the path to malignancy. This process is influenced by a combination of physiological and metabolic pathways, as well as environmental cues, and leads to abnormal cell cycle, increased cell motility, and invasive characteristics. Cancer cell organelles also present some distinct differences from those of normal cells. Cancer progression requires certain tumorigenic biochemical pathways to be activated. However, mechanical cues are also important, as they have an effect on cell differentiation and fate. A continuous biochemical–biomechanical interaction exists, which affects the mechanical properties of the cells, as well as their behavior. This review aims to focus on the mathematical relationships governing cancer mechanobiology and examine how the altered mechanical properties of a cancer cell may affect malignant progression.